Nano Holdings, Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

23

Website

www.nanomrna.co.jp

Country

Japan

Exchange

Tokyo

Minato, Japan

Nano researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer.

Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme, as well as cosmetic raw material. and changed its name to Nano Holdings, Inc. in December 2025. The company was formerly known as NANO MRNA Co.,Ltd. Incorporated in 1996, Nano is headquartered in Minato, Japan.

Key Stats

52-Week Range

¥93.00¥254.00

Beta0.38

Trailing P/EN/A

Forward P/E-3.83

Trailing EPS-12.90

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.